Tiechao Li
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Synthesis and biological activity, Cancer-related Molecular Pathways, Bioactive Compounds and Antitumor Agents, Cancer Mechanisms and Therapy
Most-Cited Works
- → Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38α MAP kinase inhibitors with excellent in vivo antiinflammatory properties(2007)115 cited
- → Synthesis, Structure−Activity Relationship, and Biological Studies of Indolocarbazoles as Potent Cyclin D1-CDK4 Inhibitors(2003)94 cited
- → Acyl Sulfonamide Anti-Proliferatives: Benzene Substituent Structure−Activity Relationships for a Novel Class of Antitumor Agents(2004)67 cited
- → Novel 1,3-disubstituted-5,10-dihydro-5,10-dioxo-1H-mbenzo[g]isochromene-3-carboxamides as potent antitumor agents(1998)63 cited
- → Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitors(2003)53 cited
- → Studies on cyclin-dependent kinase inhibitors: indolo-[2,3-a]pyrrolo[3,4-c]carbazoles versus bis-indolylmaleimides(2003)41 cited
- → Dehydrogenation by air: Preparation of 1,3-disubstituted-5,1-dioxo-5,10-dihydro-1H-benzo[g] isochromene scaffold(1998)20 cited